Trevi Therapeutics Hires Dr. Helena Brett-Smith as Chief Development Officer
Highly experienced clinical drug developer to oversee R&D functions and Company’s Phase 3 development program New Haven, CT, October 12, […]
A press release
A press release
Post Capital Partners Addresses the Changing Environment for Behavioral Health Investments at Capital Roundtable Conference
As a result of the growth in incidence and diagnosis of autism and other developmental disabilities and the evolution of
A press release
EAB Investment Group Names Former Deutsche Asset Management Investment Strategist Arnim S. Holzer to Fund Advisory Team
With advisors looking toward more actively managed platforms for investors, there is an increased need for information and communication about
A press release
Three Informa Exhibitions Shows Named in Trade Show News Network’s Prestigious “Top 25” Lists
Eighth annual awards celebrate events industry’s fastest-growing shows London, September 7, 2017 – Informa’s Global Exhibitions division has announced that
A press release
Acrow Affirms Commitment to U.S.-based Manufacturing of Highest Quality Bridges for Both Domestic and International Customers
(Parsippany, New Jersey) – 26 July 2017 – While Acrow Bridge, a leading international bridge engineering and supply company, does business
A press release
Trevi Therapeutics Raises $50 Million Series C Financing Led by New Enterprise Associates
Company continuing the development of Nalbuphine® ER in chronic pruritus conditions New Haven, CT, July 20, 2017 – Trevi Therapeutics,